Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 1
2008 2
2009 7
2010 3
2011 4
2012 4
2013 15
2014 13
2015 14
2016 15
2017 8
2018 15
2019 6
2020 11
2021 26
2022 25
2023 21
2024 23
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Glucagon-like peptide-1 receptor agonist use is associated with a lower risk of major adverse liver-related outcomes: a meta-analysis of observational cohort studies.
Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Infantino G, Di Maria G, Pinato DJ, Cabibbo G, Enea M, Mantovani A, Tilg H, Targher G, Cammà C, Petta S. Celsa C, et al. Among authors: cabibbo g. Gut. 2025 Apr 7;74(5):815-824. doi: 10.1136/gutjnl-2024-334591. Gut. 2025. PMID: 40015951
Surveillance in HCC: Making the Most of What We Have Today.
Sanduzzi-Zamparelli M, Cabibbo G. Sanduzzi-Zamparelli M, et al. Among authors: cabibbo g. Liver Int. 2025 Apr;45(4):e70057. doi: 10.1111/liv.70057. Liver Int. 2025. PMID: 40083260 No abstract available.
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma.
Rocco A, Sgamato C, Pelizzaro F, Simeon V, Coccoli P, Compare D, Pinto E, Palano G, Foschi FG, Raimondo G, Missale G, Svegliati-Baroni G, Trevisani F, Caturelli E, Brunetto MR, Vidili G, Masotto A, Magalotti D, Campani C, Gasbarrini A, Azzaroli F, Rapaccini GL, Stefanini B, Sacco R, Mega A, Giannini EG, Cabibbo G, Di Marco M, Guarino M, Chiodini P, Farinati F, Nardone G. Rocco A, et al. Among authors: cabibbo g. Hepatol Int. 2025 Mar 25. doi: 10.1007/s12072-025-10806-6. Online ahead of print. Hepatol Int. 2025. PMID: 40131621
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Celsa C, Cabibbo G, Fulgenzi CAM, Battaglia S, Enea M, Scheiner B, D'Alessio A, Manfredi GF, Stefanini B, Nishida N, Galle PR, Schulze K, Wege H, Ciccia R, Hsu WF, Vivaldi C, Wietharn B, Lin RP, Pirozzi A, Pressiani T, Dalbeni A, Natola LA, Auriemma A, Rigamonti C, Burlone M, Parisi A, Huang YH, Lee PC, Ang C, Marron TU, Pinter M, Cheon J, Phen S, Singal AG, Gampa A, Pillai A, Roehlen N, Thimme R, Vogel A, Soror N, Ulahannan S, Sharma R, Sacerdoti D, Pirisi M, Rimassa L, Lin CY, Saeed A, Masi G, Schönlein M, von Felden J, Kudo M, Cortellini A, Chon HJ, Cammà C, Pinato DJ. Celsa C, et al. Among authors: cabibbo g. Hepatology. 2025 Mar 1;81(3):837-852. doi: 10.1097/HEP.0000000000001026. Epub 2024 Jul 19. Hepatology. 2025. PMID: 39028886
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study.
Stella L, Pallozzi M, Cerrito L, Santopaolo F, Tovoli F, Hollande C, Sidali S, Stefanini B, Campani C, Pellegrini E, Cabibbo G, Marra F, Piscaglia F, Gasbarrini A, Pompili M, Bouattour M, Ponziani FR. Stella L, et al. Among authors: cabibbo g. Clin Gastroenterol Hepatol. 2025 Feb 26:S1542-3565(25)00148-X. doi: 10.1016/j.cgh.2024.12.028. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40020957 Free article.
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma.
Giannini EG, Pasta A, Plaz Torres MC, Pieri G, Cabibbo G, Sangiovanni A, Piscaglia F, Campani C, Missale G, Vidili G, Ghittoni G, Pelizzaro F, Foschi FG, Morisco F, Santi V, Svegliati-Baroni G, Azzaroli F, Saitta C, Brunetto MR, Sacco R, Ponziani FR, Boninsegna S, Nardone G, Martini A, Mega A, Sacerdoti D, Magalotti D, Vitale A, Bucci L, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Giannini EG, et al. Among authors: cabibbo g. Liver Int. 2025 Feb;45(2):e16185. doi: 10.1111/liv.16185. Liver Int. 2025. PMID: 39776202 Free PMC article.
192 results